Measurement of KIT ligand/stem cell factor: Clinical and biochemical significance

Current Opinion in Hematology

Volumn 7, Issue 3, 2000, Pages 133-142

  Nakagawa, Shigeki ^a   Kitoh, Takashi ^a,b  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Nichirei Corporation   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE PLACENTA ISOENZYME; COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 3; PLATELET DERIVED GROWTH FACTOR RECEPTOR; STEEL FACTOR; STEM CELL FACTOR;

ANIMAL CELL; CELL STRAIN 3T3; CELL STRAIN COS1; CHRONIC KIDNEY FAILURE; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE MUTATION; GERM CELL; HEMATOPOIESIS; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW; SEQUENCE HOMOLOGY; SERUM; SIGNAL TRANSDUCTION; UMBILICAL CORD BLOOD;

ANIMALS; HEMATOLOGIC DISEASES; HEMATOPOIESIS; HUMANS; LIGANDS; PROTO-ONCOGENE PROTEINS C-KIT; REPRODUCTION; SIGNAL TRANSDUCTION; STEM CELL FACTOR;

EID: 0034000142     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200005000-00002     Document Type: Review

References (69)

1. 1 Flanagan JG, Chan DC, Leder P: Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant. Cell 1991, 64:1025-1035.
2. 2 Yarden Y, Kuang W-J, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, et al.: Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for a unidentified ligand. EMBO J 1987, 6:3341-3351.
3. 3 Flanagan JG, Leder P: The kit ligand: a cell surface molecule altered in Steel mutant fibroblasts. Cell 1990, 63:185-194. This paper does not relate directly to SCF/KIT and its intracellular signaling chain. However, cross talk of phosphorylation could occur in cells that possess KIT. PKC isotopes have the chance to act on proteins relating to their signaling pathway.
4. 4 Anderson DM, William DE, Tushinski R, Gimpel S, Eisenman J, Cannizarro LA, et al.: Alternative splicing of mRNAs encoding human mast cell growth factor and localization of the gene to chromosome 12q22-24. Cell Growth Differ 1991, 2:373-378.
5. 5 Zsebo KM, Wypych J, McNiece IK, Lu HS, Smitth KA, Karkare SB, et al.: Identification, purification, and biological characterization of hematopoietic stem cell factor from Buffalo rat liver-conditioned medium. Cell 1990, 63:195-201.
6. 6 Martin FH, Suggs SV, Langley KE, Lu HS, Ting J, Okino KH, et al.: Primary structure and functional expression of rat and human stem cell factor DNAs. Cell 1990, 63:203-211.
7. 7 Bennett D: Developmental analysis of a mutation with pleiotropic effects in the mouse. J Morphol 1956, 98:199-233.
8. 8 Mayer TC, Green MC: An experimental analysis of the pigment defect caused by mutation at the W and Sl loci in mice. Dev Biol 1968, 18:62-75.
9. 9 Copeland NG, Gilbert DJ, Cho BC, Donovan PJ, Jenkins NA, Cosman D, et al.: Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles. Cell 1990, 63:175-183.
10. 10 Geissler EN, Liao M, Brook JD, Martin FH, Zsebo KM, Housman DE, Calli SJ: Stem cell factor (SCF), a novel hematopoietic growth factor and ligand for c-kit tyrosine kinase receptor, maps on human chromosome 12 between 12q14.3and 12qter. Somat Cell Mol Genet 1991, 17:207-214.
11. 11 Arakawa T. Yphantis DA, Lary JW, Narhi LO, Lu HS, Prestrelski SJ, et al.: Glycosylated and unglycosylated recombinant-derived human stem cell factors are dimeric and have extensive regular secondary structure. J Biol Chem 1991, 266:18942-18948.
12. 12 Anderson DM, Lyman SD, Baird A, Wignall JM, Eiserman J, Rauch C, et al.: Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell 1990, 63:235-243.
13. 13 Lu HS, Clogston CL, Wypych J, Fausset PR, Lauren S, Mendiaz EA, et al.: Amino acid sequence and post-translational modification of stem cell factor isolated from buffalo rat liver cell-conditioned medium. J Biochem 1991, 266:8102-8107.
14. 14 Langley KE, Bennett LG, Wyphch J, Yancik SA, Liu X-D, Westcott KR, et al.: Soluble stem cell factor in human serum. Blood 1993, 81:656-660.
15. 15 Hsu Y-R, Wu G-M, Mendiaz EA, Syed R, Wypych J, Toso R, et al.: The majority of stem cell factor exists as monomer under physiological conditions. J Biol Chem 1997, 272:6406-6415.
16. 16 Ohneda O, Fennie C, Zheng Z, Donahue C, La H, Villacorta R, et al.: Hematopoietic stem cell maintenance and differentiation are supported by embryonic aorta-gonad-mesonephros region-derived endothelium. Blood 1998, 92:908-919.
17. 17 Matsui Y, Zsebo KM, Hogan BLM: Embryonic expression of a haematopoietic growth factor encoded by the Sl locus and the ligand for c-kit. Nature 1990, 347:667-668.
18. 18 Motro B, Wojtowicz JM, Bernstein A, Kooy DVD: Steel mutant mice are deficient in hippocampal learning but not long-term potentiation. Proc Natl Acad Sci U S A 1996, 93:1808-1813.
19. 19 Heinrich MC, Dooley DC, Freed AC, Band L: Constitutive expression of steel factor gene by human stromal cells. Blood 1993, 82:771-783.
20. 20 Bernstein SE: Tissue transplantation as an analytic and therapeutic tool in hereditary anemias. Am J Surg 1970, 119:448-451.
21. 21 Li CL, Johnson GR: Stem cell factor enhances the survival but not the self-renewal of murine hematopoietic long-term repopulating cells. Blood 1994, 84:408-414.
22. 22 Miller CL, Revel VI, Halgason CD, Lansdorp PM, Eaves CJ: Impaired steel factor responsiveness differentially affects the detection and long-term maintenance of fetal liver hematopoietic stem cell in vitro. Blood 1997, 89:1214-1223.
23. 23 Keller JR, Ortiz M, Ruscetti FW: Steel factor (c-kit ligand) promotes the survival of hematopoietic stem/progenitor cells in the absence of cell division. Blood 1995, 86:1757-1764.
24. 24 Wu H, Klingmuller U, Besmer P, Lodish HF: Interaction of the erythropoietin and stem-cell-facors. Nature 1995, 37:242-246.
25. 25 Olweus J, Terstappen LW, Thompson PA, Lund JF: Expression and function of receptors for stem cell factor and erythropoietin during lineage commitment of human hematopoietic progenitor cells. Blood 1996, 88:1594-607.
26. 26 Langley KE, Wypych J, Mendiaz EA, Clogston CL, Parker VP, Farrar DH, et al.: Purification and characterization of soluble forms of human and rat stem cell factor recombinantly expressed by Escherichia coli and by Chinese hamster ovary cells. Arch Biochem Biophys 1992, 295:21-28.
27. 27 Ulich TR, del-Castillo J, McNiece IK, Yi ES, Alzona CP, Yin SM, Zsebo KM: Stem cell factor in combination with granulocyte colony-stimulating factor (CSF) or granulocyte-macrophage CSF synergistically increases granulopoiesis in vivo. Blood 1991, 78:1954-1962.
28. 28 McNiece IK, Langley KE, Zsebo KM: Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and Epo to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp Hematol 1991, 19:226-231.
29. 29 Bernstein ID, Andrews RG, Zsebo KM: Recombinant human stem cell factor enhances the formation of colonies by CD34+ and CD34+ lin cells and the generation of colony-forming cell progeny from CD34+ lin cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor. Blood 1991, 77:2316-2321.
30. 30 Briddell RA, Bruno E, Cooper RJ, Brandt JE, Hoffman R: Effect of c-kit ligand on in vitro human megakaryocytopoiesis. Blood 1991, 78:2854-2859.
31. 31 Grabarek J, Groopman JE, Lyles YR, Jiang S, Bennett L, Zsebo K, Avraham H: Human kit ligand (stem cell factor) modulates platelet activation in vitro. J Biol Chem 1994, 269:21718-21724.
32. 32 Tsai M, Takeishi T, Thompson H, Langley KE, Zsebo KM, Metcalfe DD, et al.: Induction of mast cell proliferation, maturation and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc Natl Acad Sci U S A 1991, 88:6382-6386.
33. 33 Tsai M, Tam SY, Galli SJ: Distinct patterns of early response gene expression and proliferation in mouse mast cells stimulated by stem cell factor, interleukin-3, or IgE and antigen. Eur J Immunol 1993, 23:867-872.
34. 34 Columbo M, Horowita EM, Botana LM, MacGlashan DW Jr, Bochner BS, Gillis S, et al.: The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J Immunol 1992, 149:599-608.
35. 35 Cathie IAB: Erythrogenesis impertecta. Arch Dis Child 1950, 25:313-324.
36. 36 Costa JJ, Demetri GD, Harrist TJ, Dvorak AM, Hayes DF, Merica EA, et al.: Recombinant human stem cell factor (Kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med 1996, 183:2681-2686.
37. 37 Cohen PS, Chan JP, Lipkunskaya M, Biedler JL, Seeger RC, and The Children's Cancer Group: Expression of stem cell factor and c-kit in human neuroblastoma. Blood 1994, 84:3465-3472.
38. 38 Fujio K, Everts RP, Hu Z, Marsden ER, Thorgeirsson SS: Expression of stem cell factor and its receptor, c-kit, during liver regeneration from putative stem cell in adult rat. Lab Invest 1994, 70:511-516.
39. 39 Lu HS, Clogston CL, Wypych J, Parker VP, Lee TD, Swiderek K, et al.: Post-translational processing of membrane-associated recombinant human stem cell factor expressed in Chinese hamster ovary cells. Arch Biochem Biophys 1992, 298:150-158.
40. 40 Kitoh T, Ishikawa H, Sawada S, Koshino K, Tokano Y, Hashimoto H, Nakagawa S: Significance of stem cell factor and soluble KIT in patients with systemic lupus erythematosus. Clin Rheumatol 1998, 17:293-300.
41. 41 Bowen D, Yancik D, Bennett L, Culligan D, Resser K: Serum stem cell factor concentration in patients with myelodysplastic syndromes. Br J Haematol 1993, 85:63-66.
42. 42 Kitoh T, Ishikawa H, Ishii T, Nakagawa S: Elevated SCF levels in the serum of patients with chronic renal failure. Br J Haematol 1998, 102:1151-1156. This study demonstrated much higher levels of serum SCF in CRF independent of the treatment with recombinant human erythropoietin. In addition, a significant correlation was observed between SCF and soluble KIT as indicated in Figure 2, which was determined using Spearman's ranking test and Pearson's test.
43. 43 Kawakita M, Yonemura Y, Miyake H, Ohkubo T, Asou N, Hayakawa K, et al.: Soluble c-kit molecule in serum from healthy individuals and patients with haemopoietic disorders. Br J Haematol 1995, 91:23-29.
44. 44 Brezin AL, Brezin JH, Raible DG, Schwarz LB, Schulman ES: Elevated stem cell factor and alpha-protryptase in uremia. Proceedings of the 55th Annual Meeting of the American Academy of Allergy Asthma & Immunology. J Allergy Clin Immunol 1999, 103:899.
45. 45 Francos GC: Elevated plasma histamine in chronic uremia. Int J Dermatol 1991, 30:884-889.
46. 46 Neiman RS, Bischel MD, Lukes RJ: Uraemia and mast-cell proliferation. Lancet 1972, 1:959.
47. 47 Kihira C, Mizutani H, Asahi K, Hamanaka H, Shimizu M: Increased cutaneous immunoreactive stem cell factor expression and serum stem cell factor in systemic scleroderma. J Dermatol Sci 1999, 20:72-78.
48. 48 Hawkins RA, Claman HN, Clark AF, Steigerwald JC: Increased dermal cell populations in progressive systemic sclerosis. Ann Intern Med 1985, 102:182-186.
49. 49 To LB, Haylock DN, Simmons PJ, Juttner CA: The biology and clinical uses of blood stem cells. Blood 1997, 89:2233-2258.
50. 50 Storb R, Deeg J, Whitehead J, Appelbaum F, Beatty P, Bensinger W, et al.: Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986, 314:729-735.
51. 51 Storb R, Degg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W, et al.: Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood 1986, 68:119-125.
52. 52 Nash RA, Pineiro LA, Storv R, Deeg HJ, Fitzsimmons WE, Furlong T, et al.: FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors. Blood 1996, 88:3634-3641.
53. 53 Moskowitz CH, Stiff P, Gordon MS, McNiece I, Ho AD, Costa JJ, et al.: Recombinant methionyl human stem cell factor and filgrastim for peripheral blood progenitor cell mobilization and transplantation in non-Hodgkin's lymphoma patients: results of a phase I/II trial. Blood 1997, 89:3136-3147.
54. 54 Shpall EJ, Wheeler CA, Turner SA, Yanovich S, Brown RA, Pecora AL, et al.: A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients. Blood 1999, 93:2491-2501. This important study demonstrated the possibility that r-hSCF is useful for clinical applications. Risks for recipients of allogeneic transplants and for donors of bone marrow have motivated changes to autologous transplantation.
55. 55 Broxmeyer HE: Questions to be answered regarding umbilical cord blood hematopoietic stem and progenitor cells and their use in transplantation. Transfusion 1995, 35:694-702.
56. 56 Broxmeyer HE, Douglas GW, Hangoc G, Cooper S, Bard J, English D, et al.: Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A 1989, 86:3828-3832.
57. 57 Gluckman E, Broxmeyer HE, Auerbach AD, Friedman HS, Douglas GW, Devergie A, et al.: Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989, 321:1174-1178.
58. 58 Broxmeyer HE, Hangoc G: Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci U S A 1992, 89:4109-4113.
59. 59 Carow CE, Hangoc G, Cooper SH, Williams DE, Broxmeyer HE: Mast cell growth factor (c-kit ligand) supports the growth of human multipotential progenitor cells with a high replating potential. Blood 1991, 78:2216-2221.
60. 60 Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM: Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci U S A 1994, 91:9857-9860.
61. 61 Sandell LL, Zakian VA: Loss of a yeast telomere: arrest, recovery, and chromosome loss. Cell 1993, 75:729-739.
62. 62 Arrighi J-F, Hauser C, Chapuis B, Zubler RH, Kindler V: Long-term culture of human CD34+ progenitors with FLT3-ligand, thrombopoietin, and stem cell factor induces extensive amplification of a CD34-CD14-and a CD34-CD14+ dendritic cell precursor. Blood 1999, 93:2244-2252.
63. 63 Perry AR, Peniket AJ, Watts MJ, Leverett D, Coldstone AH, Lonch DC: Peripheral blood stem cell versus autologous bone marrow transplantation for Hodgkin's disease: equivalent survival outcome in a single-centre matched-pair analysis. Br J Haematol 1999, 105:280-287.
64. 64 Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991, 9:271-296.
65. 65 Haslauer M, Baltensperger K, Porzig H: Erythropoietin-and stem cell factor-induced DNA synthesis in normal human erythroid progenitor cells requires activation of protein kinase Cα and is strongly inhibited by thrombin. Blood 1999, 94:114-126.
66. 66 Mufson RA: The role of serine/threonine phosphorylation in hematopoietic cytokine receptor signal transduction. FASEB J 1997, 11:37-44.
67. 67 Wu H, Klingmuller U, Acurio A, Hsiao JG, Lodish HF: Functional interaction of erythropoietin and stem cell factor receptors is essential for erythroid colony formation. Proc Natl Acad Sci U S A 1997, 94:1806-1810.
68. 68 Vosseller K, Stella G, Yee NS, Besmer P: c-kit receptor signaling through its phosphatidylinositide-3′-kinase-binding site and protein kinase C: role in mast cell enhancement of degranulation, adhesion, and membrane ruffling. Mol Biol Cell 1997, 8:909-922.
69. 69 Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, Parker PJ: Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 1998, 281:2042-2045.